Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Captor Therapeutics S.A. Director's Dealing 2026

Feb 26, 2026

5552_rns_2026-02-26_62bd4530-e77f-4bdf-9553-3dff3f90814e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Notification on transaction/transactions* referred to

in Article 19(1) of MAR

1 Data of the person discharging managerial responsibilities / person closely associated with such person
a) Entity name/Last name Sylvain Cottens
2 Reason for submitting the notification
a) Job title/status SVP Chemistry
b) Original notification / change Original notification
3 Data of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Entity name "CAPTOR THERAPEUTICS" SPÓŁKA AKCYJNA
b) LEI 259400JHH1S2I2S4O735
4 Details of the transaction: please fill in this field for (i) each instrument type; (ii) each transaction type; (iii) each date; and (iv) each trading venue
a) Description of the financial instrument, instrument type Identification code Common shares ISIN: PLCPTRT00014
b) Transaction type Acquisition
c) Price and volume Price Volume
81,4 PLN 28
81,6 PLN 120
81,8 PLN 607
82 PLN 345
d) Aggregate information - Total volume - Price 1100
81,83 PLN
e) Transaction date 2026-02-26
f) Trading venue XWAR – Warsaw Stock Exchange/Equities/Main Market
  • Delete as appropriate